Abstract
This review of iPSCs to treat T1D provides a current assessment of the challenges and potential for this proposed new therapy.
Full Text
Sign-in/Register to access full text options
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have